Insider Buy/Sell Details for the Healthcare Sector — May 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1780)
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
5,072
Price
$69.22
Total Value
$351.10K
Shares Held After
255,377
% of Holdings
1.9%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
6,725
Price
$68.30
Total Value
$459.33K
Shares Held After
260,449
% of Holdings
2.5%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
2,256
Price
$67.57
Total Value
$152.43K
Shares Held After
267,174
% of Holdings
0.8%
Serina Therapeutics, Inc. (SER)
WILSON KAREN J — Director
Shares
10,000
Price
$1.77
Total Value
$17.70K
Shares Held After
10,000
% of Holdings
100.0%
ClearPoint Neuro, Inc. (CLPT)
Klein Matthew B. — Director
Shares
16,000
Price
$11.59
Total Value
$185.44K
Shares Held After
46,935
% of Holdings
25.4%
Precipio, Inc. (PRPO)
SANDBERG RICHARD A — Director
Shares
900
Price
$25.02
Total Value
$22.52K
Shares Held After
3,000
% of Holdings
23.1%
Amylyx Pharmaceuticals, Inc. (AMLX)
Firestone Karen — Director
Shares
3,800
Price
$13.51
Total Value
$51.34K
Shares Held After
66,900
% of Holdings
5.7%
electroCore, Inc. (ECOR)
Errico Thomas J. — Director
Shares
9,992
Price
$5.99
Total Value
$59.85K
Shares Held After
360,071
% of Holdings
2.8%
INTUITIVE SURGICAL INC (ISRG)
Brosius Mark — EVP & Chief Mfg and Supply Cha
Shares
18
Price
$446.04
Total Value
$8.03K
Shares Held After
1,541
% of Holdings
1.2%
Moderna, Inc. (MRNA)
AFEYAN NOUBAR — Director
Shares
9,263
Price
$46.84
Total Value
$433.88K
Shares Held After
3,924
% of Holdings
70.2%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
12,820
Price
$6.15
Total Value
$78.84K
Shares Held After
700,000
% of Holdings
1.8%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
212
Price
$20.20
Total Value
$4.28K
Shares Held After
1,946
% of Holdings
9.8%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
212
Price
$20.20
Total Value
$4.28K
Shares Held After
1,946
% of Holdings
9.8%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
212
Price
$20.20
Total Value
$4.28K
Shares Held After
1,946
% of Holdings
9.8%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
212
Price
$20.20
Total Value
$4.28K
Shares Held After
1,946
% of Holdings
9.8%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
880
Price
$20.20
Total Value
$17.77K
Shares Held After
38,061
% of Holdings
2.3%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
1,035
Price
$20.20
Total Value
$20.90K
Shares Held After
44,781
% of Holdings
2.3%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
420
Price
$20.20
Total Value
$8.48K
Shares Held After
21,479
% of Holdings
1.9%
ARDELYX, INC. (ARDX)
Kelliher Mike — Chief Business Officer
Shares
2,478
Price
$6.27
Total Value
$15.53K
Shares Held After
357,418
% of Holdings
0.7%
ARDELYX, INC. (ARDX)
Kelliher Mike — Chief Business Officer
Shares
1,870
Price
$6.27
Total Value
$11.72K
Shares Held After
359,896
% of Holdings
0.5%
ARDELYX, INC. (ARDX)
Kelliher Mike — Chief Business Officer
Shares
2,900
Price
$6.27
Total Value
$18.18K
Shares Held After
361,766
% of Holdings
0.8%
REGIONAL HEALTH PROPERTIES, INC (RHEP)
Morrison Brent — Director
Shares
12,000
Price
$2.01
Total Value
$24.12K
Shares Held After
11,300
% of Holdings
106.2%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
2,405
Price
$6.27
Total Value
$15.07K
Shares Held After
417,972
% of Holdings
0.6%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
2,427
Price
$6.27
Total Value
$15.21K
Shares Held After
420,377
% of Holdings
0.6%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
3,166
Price
$6.27
Total Value
$19.84K
Shares Held After
422,804
% of Holdings
0.7%
ARDELYX, INC. (ARDX)
Brady James Parker — Chief Human Resources Officer
Shares
1,846
Price
$6.27
Total Value
$11.57K
Shares Held After
261,066
% of Holdings
0.7%
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)
JW Asset Management, LLC — 10% Owner
Shares
16,999
Price
$71.40
Total Value
$1.21M
Shares Held After
2,981,115
% of Holdings
0.6%
ARVINAS, INC. (ARVN)
Teel Randy — Director
Shares
2,209
Price
$9.04
Total Value
$19.96K
Shares Held After
285,009
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
Bishop John E — Chief Technical and Quality Officer
Shares
2,306
Price
$6.27
Total Value
$14.45K
Shares Held After
336,845
% of Holdings
0.7%
ARDELYX, INC. (ARDX)
Hohenleitner Susan — Chief Financial Officer
Shares
1,455
Price
$6.27
Total Value
$9.12K
Shares Held After
229,078
% of Holdings
0.6%
ARDELYX, INC. (ARDX)
Reilly Joseph James — Senior Vice President and Chief Accounting Officer
Shares
1,036
Price
$6.27
Total Value
$6.49K
Shares Held After
149,836
% of Holdings
0.7%
ARDELYX, INC. (ARDX)
Reilly Joseph James — Senior Vice President and Chief Accounting Officer
Shares
2,683
Price
$6.27
Total Value
$16.82K
Shares Held After
149,107
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,197
Price
$566.12
Total Value
$1.24M
Shares Held After
18,876
% of Holdings
10.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,765
Price
$565.10
Total Value
$997.41K
Shares Held After
21,073
% of Holdings
7.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,081
Price
$564.10
Total Value
$1.17M
Shares Held After
22,838
% of Holdings
8.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,677
Price
$563.12
Total Value
$1.51M
Shares Held After
24,919
% of Holdings
9.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
920
Price
$562.01
Total Value
$517.05K
Shares Held After
27,596
% of Holdings
3.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
320
Price
$560.03
Total Value
$179.21K
Shares Held After
28,516
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$557.85
Total Value
$22.31K
Shares Held After
28,836
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$566.42
Total Value
$90.63K
Shares Held After
40,513
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,259
Price
$566.02
Total Value
$1.28M
Shares Held After
40,673
% of Holdings
5.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,840
Price
$564.87
Total Value
$1.04M
Shares Held After
42,932
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,242
Price
$563.77
Total Value
$1.26M
Shares Held After
44,772
% of Holdings
4.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,760
Price
$562.98
Total Value
$990.84K
Shares Held After
47,014
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
919
Price
$561.97
Total Value
$516.45K
Shares Held After
48,774
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$560.03
Total Value
$156.81K
Shares Held After
49,693
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$557.85
Total Value
$22.31K
Shares Held After
49,973
% of Holdings
0.1%
Oruka Therapeutics, Inc. (ORKA)
Dambkowski Carl — Director
Shares
13,235
Price
$59.97
Total Value
$793.66K
Shares Held After
73,743
% of Holdings
15.2%
Oruka Therapeutics, Inc. (ORKA)
Dambkowski Carl — Director
Shares
53,447
Price
$59.10
Total Value
$3.16M
Shares Held After
86,978
% of Holdings
38.1%
Oruka Therapeutics, Inc. (ORKA)
Dambkowski Carl — Director
Shares
38,318
Price
$58.43
Total Value
$2.24M
Shares Held After
140,425
% of Holdings
21.4%
Showing 351–400 of 1780 transactions (page 8 of 36)